Detalles de la búsqueda
1.
Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset.
PLoS Pathog
; 12(8): e1005774, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27509048
2.
HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds.
Retrovirology
; 13(1): 48, 2016 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27388013
3.
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.
Retrovirology
; 10: 102, 2013 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24059682
4.
A genetic variation in fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation.
AIDS
; 37(13): 1959-1969, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598360
5.
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection.
AIDS
; 37(15): 2297-2304, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37702421
6.
Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies.
J Virol
; 85(14): 6986-95, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21593147
7.
Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic.
J Virol
; 85(14): 7236-45, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21561918
8.
Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression.
AIDS
; 34(9): 1303-1312, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32287057
9.
Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodies.
AIDS
; 30(14): 2179-84, 2016 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27258397
10.
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.
AIDS Res Hum Retroviruses
; 32(10-11): 1135-1142, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26910384
11.
Early development of broadly reactive HIV-1 neutralizing activity in elite neutralizers.
AIDS
; 28(8): 1237-40, 2014 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24556870
12.
Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.
PLoS One
; 8(1): e54684, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23372753
13.
The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.
Virology
; 422(1): 70-80, 2012 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22047989
14.
Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control.
AIDS
; 25(18): 2217-26, 2011 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21860345
15.
Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course.
PLoS One
; 6(7): e22208, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21811574
16.
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level.
Nat Med
; 16(9): 995-7, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20802498
17.
Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.
J Virol
; 81(16): 8533-42, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17522228
18.
Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro.
Virology
; 363(2): 447-53, 2007 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-17355886
19.
T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates.
Virology
; 359(1): 92-104, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17052738
Resultados
1 -
19
de 19
1
Próxima >
>>